Navigation Links
Aware, Inc. Reports Second Quarter 2012 Financial Results
Date:7/26/2012

0602,1842,111General and administrative

1,0751,7892,0602,986Total costs and expenses

4,9656,1969,65711,982Income (loss) from operations

369(283)1,411290Gain on sale of patent assets

71,226-71,226-Other income

59-85-Interest income

40169235Income (loss) before provision for income taxes

71,694(267)72,814325Provision for income taxes

16,768-16,7702Net income (loss)$54,926($267)$56,044$323Net income (loss) per share – basic

$2.52($0.01)$2.64$0.02Net income (loss) per share – diluted$2.49($0.01)$2.60$0.02Weighted average shares – basic

21,75720,70021,24120,461Weighted average shares – diluted

22,09920,70021,58320,821AWARE, INCCONDENSED CONSOLIDATED BALANCE SHEETS(In thousands)(unaudited)June 30,2012December 31,2011ASSETSCash and investments$101,058$47,304Accounts receivable, net4,3173,546Inventories, net265547Property and equipment, net6,0646,232Other assets, net239222Total assets$111,943$57,851LIABILITIES AND STOCKHOLDERS' EQUITYTotal current liabilities$7,730$2,814Long-term deferred revenue358462Total stockholders' equity103,85554,575Total liabilities and stockholders' equity$111,943$57,851


'/>"/>
SOURCE Aware, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology news :

1. Aware, Inc. Reports First Quarter 2012 Financial Results
2. GEN reports on growth of tissue engineering revenues
3. BGI reports the completed sequence of foxtail millet genome
4. Radiologists study necessity of additional imaging recommendations in PET/CT oncologic reports
5. NOAA plankton surveys, second longest in the North Atlantic, add to new global effort
6. U-M forecasters predict second-smallest Gulf of Mexico dead zone
7. Second Middle East & Africa Osteoporosis Meeting to take place in Jordan
8. Second-generation drug used for hypertension aids heart function independent of blood pressure
9. BioLife Solutions Announces 7th Consecutive Quarter of Record Revenue
10. One-quarter of grouper species being fished to extinction
11. Study examines autism law, financial burdens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2015)... , Aug. 18, 2015  Navitas ... key contributor to the Submission Content Management ... IRISS, a non-profit forum. Dedicated to the Implementation ... a neutral platform for industry, vendors, health ... information and work towards a standard method ...
(Date:8/12/2015)... 2015 As the digital payment ... and advanced biometrics technology is accelerating beyond expectations.  While ... on using their credit cards, the digital currency, mobile ... payment services led by companies in the space such ... Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ...
(Date:8/10/2015)... , August 10, 2015 ... Eye Tracking Technology for more than two decades, announces ... for integration into all consumer display formats. The SMI ... integration of eye tracking into consumer tablets, laptops, desktop ... smart glasses. Omnivision,s leading sensor technology contributes to the ...
Breaking Biology News(10 mins):Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3
... Researchers at the University of Iowa have created a ... putting DNA into a nano-sized particle that delivers bone-producing ... on a collagen platform seeded with particles containing the ... bio patch successfully regrew bone fully enough to cover ...
... drug-resistant breast cancer cells, according to a study published ... are just as small, or even smaller, than many ... of healthy and sick cells, which make them interesting ... In the present study, researchers from Karolinska Institutet ...
... for Brain Science announced today that it contracted ... and manufacture a state-of-the-art sensor array for recording ... for Brain Science in partnership with the Howard ... the Wellcome Trust and University College London (UCL), ...
Cached Biology News:A bio patch that can regrow bone 2A bio patch that can regrow bone 3Nanoparticles can overcome drug resistance in breast cancer cells 2Allen Institute for Brain Science partners with imec for development of next-generation tools 2
(Date:8/27/2015)... ... August 27, 2015 , ... Capital Edge Consulting , a ... is pleased to announce their ranking as one of the top 5000 companies listed ... private companies across the nation. , “It is truly an honor to be recognized ...
(Date:8/27/2015)... - Portage Biotech Inc. ("Portage") (OTC Market: PTGEF, ... Company Limited (Biohaven), announced today that dosing has ... a glutamate modulating agent. Biohaven filed an investigational ... clearance from the U.S. Food and Drug Administration ... 54% equity interest in Biohaven, a private company. ...
(Date:8/27/2015)... , Aug. 27, 2015  Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, today announced that executives ... in the month of September.  , ... at Rodman & Renshaw,s 17th Annual Global Investment Conference ... at the St. Regis Hotel in New ...
(Date:8/27/2015)... , Aug. 27, 2015 HUYA Bioscience ... meeting of the Japan Society of HTLV-1, held this ... Auditorium. The purpose of the Society is to promote ... the development of medical technology and research related to ... welfare. "HUYA is proud to support this ...
Breaking Biology Technology:Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4Asterias Biotherapeutics to Present at Upcoming Investor Conferences 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 4
... profile of Ranexa -, - Conference call ... PALO ALTO, Calif., Nov. 6 CV ... the U.S. Food and Drug,Administration (FDA) has approved ... tablets) for the treatment of,chronic angina. The new ...
... ALine increases microfabrication business development capabilities by hiring laboratory reagent ... ... (PRWEB) November 6, 2008 -- ALine, Inc., a high-tech provider ... Roger Anderson, PhD, as the Vice President of Operations. Dr. ...
... and Manufacturing Process Documentation for Customer ... ... Inc.,(OTC Bulletin Board: BLFS), a leading developer and marketer of ... today announced that it has submitted a Master File to ...
Cached Biology Technology:FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c 2FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c 3FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c 4FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c 5ALine, Inc. Expands Management, Adding Roger Anderson, Ph.D., as VP of Operations 2BioLife Solutions Submits FDA Master File on HypoThermosol(R) Preservation and Storage Media for Cells, Tissues 2BioLife Solutions Submits FDA Master File on HypoThermosol(R) Preservation and Storage Media for Cells, Tissues 3
PCR System for increased fidelity, yield and length of PCR products. Amplifies targets up to 10 kb from human genomic DNA....
...
US Pharmacopoeia Purified-Water/Water-for-Injection Quality Water...
Immunogen: Secretory component isolated from human colostrum. Storage: 4 C...
Biology Products: